Skip to main content
. 2014 Jun;21(6):877–885. doi: 10.1128/CVI.00035-14

FIG 2.

FIG 2

Antigens that differentiate Dryvax from the monoclonal ACAM2000 vaccine. Serum antibody responses from 71 individuals receiving a primary vaccination with Dryvax (n = 10) or ACAM2000 (n = 61) were measured by protein microarray. Data shown represent a significant difference (P < 0.05) in antibody response between vaccinated groups of individuals.